Marker and probe composition for thyroid cancer screening and application of marker and probe composition
A technology of thyroid cancer and markers, applied in the biological field, can solve problems such as over-medication, delayed surgery opportunities, and affecting thyroid function, achieving high sensitivity and accuracy, and reducing harm
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0128] The preparation of the chip is mainly based on a glass sheet or a silicon sheet as a carrier, and oligonucleotide fragments or cDNAs are arranged on the carrier in sequence as probes by means of in situ synthesis and micro-array.
[0129] The chip of the present invention is based on the signal detection of DNA sequence hybridization after bisulfite treatment. Bisulfite treatment is to change unmethylated cytosine into uracil, while methylated cytosine remains unchanged. Change, then convert uracil to thymine, and finally carry out chip hybridization; finally judge the type of base added according to the fluorescent color, and then determine whether the site is methylated.
[0130] The present invention provides a method for thyroid cancer screening, which comprises:
[0131] detect the methylation level of the marker, and
[0132] The risk of the subject suffering from thyroid cancer is judged based on the methylation level, and the marker is selected from one of the ...
Embodiment 1
[0136] Example 1. Screening markers
[0137] 1) Sample collection: Download the 450k methylation microarray cancer tissue data in TCGA, involving a total of 7,769 cancer tissue samples of 26 types of tumors, including adrenocortical carcinoma (80), bladder urothelial carcinoma (409), acute myeloid Leukemia (140), brain low-grade glioma (654), breast cancer (740), cervical cancer (286), colorectal cancer (348), esophageal cancer (183), uveal melanoma (80), head and neck squamous Stem cell carcinoma (527), kidney cancer (660), liver cancer (377), lung adenocarcinoma (425), lung squamous cell carcinoma (372), diffuse large B-cell lymphoma (29), ovarian serous cystadenocarcinoma ( 10), pancreatic cancer (184), mesothelioma (116), prostate cancer (488), skin melanoma (104), sarcoma (117), thyroid cancer (397), testicular cancer (134), thymus cancer (94 ), thyroid cancer (506), endometrial cancer (309). For healthy people, Boercheng collected plasma from 38 healthy people, and the...
Embodiment 2
[0154] Example 2. Sample preparation, library building and verification methods
[0155] For a marker obtained in Example 1 that can distinguish thyroid cancer from healthy people, it was verified in a plasma sample, and the specific detection method was as follows:
[0156] 1.1.cfDNA extraction and purification
[0157] 1.1.1. Plasma sample preparation:
[0158] Centrifuge the blood sample at 2000 g for 10 min at 4°C and transfer the plasma to a new centrifuge tube. Centrifuge the plasma sample at 16000g for 10min at 4°C, and proceed to the next step according to the type of collection tube used. The type of collection tube used in this experiment is other.
[0159] Table 1
[0160]
[0161] 1.1.2. Lysis and conjugation
[0162] 1.1.2.1. Prepare the binding solution / bead mixture according to the table below and mix thoroughly.
[0163] Table 2
[0164]
[0165] Add an appropriate volume of plasma sample.
[0166] 1.1.2.2. Thoroughly mix the plasma sample and bind...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com